A sick dog, desperate owner, and a bunch of chatbots made for a great story. The actual science was much messier.

A heart-wrenching tale unfolds as a devoted pet owner faces the challenges of a sick dog, navigating a world filled with chatbots. However, the reality behind the science is far more complicated than ...

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential ...

"Falling vaccination rates, inadequate health policy, and a lack of preparedness can trigger a crisis that brings an entire ...

The updated 2024-2025 mRNA COVID-19 vaccine was linked to moderate protection against severe COVID-19 outcomes, including hospitalizations.

When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology ...

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines in areas of high unmet need in rare muscle diseases, ...

Penn Engineers have redesigned the lipid nanoparticles (LNPs) used to deliver mRNA vaccines, showing that subtle changes in lipid chemistry can influence immune cell metabolism and reduce inflammation ...

He used ChatGPT and Google’s DeepFold to analyze Rose’s DNA and got a university to manufacture a vaccine. The cancer wasn’t ...

Both Bank of America and JPMorgan are hosting conferences on the industrial sector, featuring presentations from companies including Boeing (BA) and American Airlines (AAL). Delta Air Lines (DAL) ...

The tale of this heartbroken tech entrepreneur, his tumour-riddled rescue dog and a cure for cancer has leading scientists ...